Edition:
United Kingdom

Arsanis Inc (ASNS.OQ)

ASNS.OQ on NASDAQ Stock Exchange Global Market

1.92USD
13 Aug 2018
Change (% chg)

$-0.34 (-15.04%)
Prev Close
$2.26
Open
$2.25
Day's High
$2.25
Day's Low
$1.92
Volume
20,594
Avg. Vol
20,772
52-wk High
$27.83
52-wk Low
$1.92

Select another date:

Thu, May 10 2018

BRIEF-Arsanis Posts Qtrly Loss Per Share $0.74

* ASN100 PHASE 2 TRIAL INTERIM ANALYSIS RESULTS EXPECTED IN LATE JUNE

BRIEF-Arsanis Inc - Out Licenses Preclinical Stage E. Coli Monoclonal Antibodies

* BB100 SECURED EXCLUSIVE,WORLDWIDE PRECLINICAL DEVELOPMENT LICENSE, OPTION TO DEVELOPMENT, COMMERCIALIZATION LICENSE, TO MABS TARGETING E. COLI Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)

BRIEF-Arsanis Granted Key Patents For ASN100 Covering Cross-Neutralizing S. Aureus Toxin Antibodies

* ARSANIS GRANTED KEY PATENTS FOR ASN100 COVERING CROSS-NEUTRALIZING S. AUREUS TOXIN ANTIBODIES Source text for Eikon: Further company coverage:

BRIEF-Arsanis Reports Q4 Net Loss $1.68 Per Share

* ARSANIS REPORTS FINANCIAL RESULTS AND HIGHLIGHTS FOR FOURTH QUARTER AND FULL YEAR 2017

Select another date: